Cargando…

The effect of deadlines on cancer screening completion: a randomized controlled trial

Cancer is the second leading cause of death in the United States. Although screening facilitates prevention and early detection and is one of the most effective approaches to reducing cancer mortality, participation is low—particularly among underserved populations. In a large, preregistered field e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lieberman, Alicea, Gneezy, Ayelet, Berry, Emily, Miller, Stacie, Koch, Mark, Argenbright, Keith E., Gupta, Samir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260724/
https://www.ncbi.nlm.nih.gov/pubmed/34230556
http://dx.doi.org/10.1038/s41598-021-93334-1
_version_ 1783718866585649152
author Lieberman, Alicea
Gneezy, Ayelet
Berry, Emily
Miller, Stacie
Koch, Mark
Argenbright, Keith E.
Gupta, Samir
author_facet Lieberman, Alicea
Gneezy, Ayelet
Berry, Emily
Miller, Stacie
Koch, Mark
Argenbright, Keith E.
Gupta, Samir
author_sort Lieberman, Alicea
collection PubMed
description Cancer is the second leading cause of death in the United States. Although screening facilitates prevention and early detection and is one of the most effective approaches to reducing cancer mortality, participation is low—particularly among underserved populations. In a large, preregistered field experiment (n = 7711), we tested whether deadlines—both with and without monetary incentives tied to them—increase colorectal cancer (CRC) screening. We found that all screening invitations with an imposed deadline increased completion, ranging from 2.5% to 7.3% relative to control (ps < .004). Most importantly, individuals who received a short deadline with no incentive were as likely to complete screening (9.7%) as those whose invitation included a deadline coupled with either a small (9.1%) or large declining financial incentive (12.0%; ps = .57 and .04, respectively). These results suggest that merely imposing deadlines—especially short ones—can significantly increase CRC screening completion, and may also have implications for other forms of cancer screening.
format Online
Article
Text
id pubmed-8260724
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-82607242021-07-08 The effect of deadlines on cancer screening completion: a randomized controlled trial Lieberman, Alicea Gneezy, Ayelet Berry, Emily Miller, Stacie Koch, Mark Argenbright, Keith E. Gupta, Samir Sci Rep Article Cancer is the second leading cause of death in the United States. Although screening facilitates prevention and early detection and is one of the most effective approaches to reducing cancer mortality, participation is low—particularly among underserved populations. In a large, preregistered field experiment (n = 7711), we tested whether deadlines—both with and without monetary incentives tied to them—increase colorectal cancer (CRC) screening. We found that all screening invitations with an imposed deadline increased completion, ranging from 2.5% to 7.3% relative to control (ps < .004). Most importantly, individuals who received a short deadline with no incentive were as likely to complete screening (9.7%) as those whose invitation included a deadline coupled with either a small (9.1%) or large declining financial incentive (12.0%; ps = .57 and .04, respectively). These results suggest that merely imposing deadlines—especially short ones—can significantly increase CRC screening completion, and may also have implications for other forms of cancer screening. Nature Publishing Group UK 2021-07-06 /pmc/articles/PMC8260724/ /pubmed/34230556 http://dx.doi.org/10.1038/s41598-021-93334-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Lieberman, Alicea
Gneezy, Ayelet
Berry, Emily
Miller, Stacie
Koch, Mark
Argenbright, Keith E.
Gupta, Samir
The effect of deadlines on cancer screening completion: a randomized controlled trial
title The effect of deadlines on cancer screening completion: a randomized controlled trial
title_full The effect of deadlines on cancer screening completion: a randomized controlled trial
title_fullStr The effect of deadlines on cancer screening completion: a randomized controlled trial
title_full_unstemmed The effect of deadlines on cancer screening completion: a randomized controlled trial
title_short The effect of deadlines on cancer screening completion: a randomized controlled trial
title_sort effect of deadlines on cancer screening completion: a randomized controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260724/
https://www.ncbi.nlm.nih.gov/pubmed/34230556
http://dx.doi.org/10.1038/s41598-021-93334-1
work_keys_str_mv AT liebermanalicea theeffectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial
AT gneezyayelet theeffectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial
AT berryemily theeffectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial
AT millerstacie theeffectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial
AT kochmark theeffectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial
AT argenbrightkeithe theeffectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial
AT guptasamir theeffectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial
AT liebermanalicea effectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial
AT gneezyayelet effectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial
AT berryemily effectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial
AT millerstacie effectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial
AT kochmark effectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial
AT argenbrightkeithe effectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial
AT guptasamir effectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial